SCHEMBL29562425

SCHEMBL29562425

Nc1ccc(Cl)c(C(=O)OCc2ccccc2)c1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
ALDH1A1 P00352 6/20 0.45
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
PRKCZ Q05513 1/20 0.42
MAPT P10636 3/20 0.41
RAB9A P51151 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAOB P27338 1/20 0.41
ADORA2A P29274 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MAPK1 P28482 1/20 0.41
TSHR P16473 1/20 0.40
NPC1 O15118 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL913073 1.00 KMT2A (0.47) KMT2ATDP1SLC6A2SLC6A3ALDH1A1
SCHEMBL411135 0.86 ALDH1A1 (0.50) KMT2ATDP1SLC6A2SLC6A3ALDH1A1
SCHEMBL26075291 0.83 TDP1 (0.47) KMT2ATDP1SLC6A2SLC6A3ALDH1A1
SCHEMBL9683658 0.81 TDP1 (0.51) KMT2ATDP1SLC6A2SLC6A3ALDH1A1
SCHEMBL914503 0.81 TDP1 (0.47) KMT2ATDP1SLC6A2SLC6A3ALDH1A1
SCHEMBL3793069 0.81 ALDH1A1 (0.51) KMT2ATDP1SLC6A2SLC6A3ALDH1A1
SCHEMBL3018457 0.80 ALDH1A1 (0.45) KMT2AALDH1A1LMNAPOLBCA1
SCHEMBL26075682 0.79 ALDH1A1 (0.50) KMT2ATDP1SLC6A2SLC6A3ALDH1A1
SCHEMBL24874101 0.78 TDP1 (0.51) KMT2ATDP1SLC6A2SLC6A3ALDH1A1
SCHEMBL28199360 0.78 ALDH1A1 (0.55) KMT2ATDP1SLC6A2SLC6A3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3990437-A1 QUINAZOLIN-4-ONE DERIVATIVES USEFUL FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS Array Biopharma, Inc. (US) 2022-05-04 EP disclosed